These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37161939)

  • 1. Prevalence and risk factors for pulmonary embolism in children with sickle cell disease: an institutional retrospective cohort study.
    Bala N; Stanek J; Rodriguez V; Villella A
    Blood Coagul Fibrinolysis; 2023 Jul; 34(5):289-294. PubMed ID: 37161939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study.
    Bala N; Stanek J; Rodriguez V; Villella A
    Pediatr Hematol Oncol; 2023; 40(5):433-445. PubMed ID: 36645839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and outcomes of pulmonary embolism with sickle cell disease: Analysis of the Nationwide Inpatient Sample, 2016-2020.
    Ilerhunmwuwa NP; Adeniran O; Inyang L; Wasifuddin M; Hakobyan N; Perry JC; Abdul Khader AHS; Tahir M; Wang JC
    Eur J Haematol; 2023 Sep; 111(3):441-448. PubMed ID: 37293798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease.
    Stein PD; Beemath A; Meyers FA; Skaf E; Olson RE
    Am J Med; 2006 Oct; 119(10):897.e7-11. PubMed ID: 17000225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.
    Naik RP; Streiff MB; Haywood C; Segal JB; Lanzkron S
    J Thromb Haemost; 2014 Dec; 12(12):2010-6. PubMed ID: 25280124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of venous thromboembolism in patients with sickle cell disease undergoing noncardiovascular surgery.
    Osei SK; Long GW; Sharrak A; Derias N; Goodson R; Callahan RE; Studzinski DM; Brown OW
    J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):543-552. PubMed ID: 36574902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study.
    Kumar R; Stanek J; Creary S; Dunn A; O'Brien SH
    Blood Adv; 2018 Feb; 2(3):285-291. PubMed ID: 29431623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary embolism in sickle cell disease: a case-control study.
    Novelli EM; Huynh C; Gladwin MT; Moore CG; Ragni MV
    J Thromb Haemost; 2012 May; 10(5):760-6. PubMed ID: 22417249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which adults with sickle cell disease need an evaluation for pulmonary embolism?
    El-Amin N; Lauzon SD; Nietert PJ; Kanter J
    Br J Haematol; 2021 Nov; 195(3):447-455. PubMed ID: 34472094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Sickle Cell Disease With Severe Maternal Morbidity.
    Ha TK; Boulet SL; Cotsonis G; Geary F; Jamieson DJ; Lindsay M
    Obstet Gynecol; 2023 Jan; 141(1):163-169. PubMed ID: 36701616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.
    Brunson A; Lei A; Rosenberg AS; White RH; Keegan T; Wun T
    Br J Haematol; 2017 Jul; 178(2):319-326. PubMed ID: 28369826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis.
    Noubiap JJ; Temgoua MN; Tankeu R; Tochie JN; Wonkam A; Bigna JJ
    Thromb J; 2018; 16():27. PubMed ID: 30305805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease.
    Srisuwananukorn A; Raslan R; Zhang X; Shah BN; Han J; Gowhari M; Molokie RE; Gordeuk VR; Saraf SL
    Blood Adv; 2020 May; 4(9):1978-1986. PubMed ID: 32384541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance-A retrospective cohort study.
    Ramsey SD; Bender MA; Li L; Johnson KM; Jiao B; Devine B; Basu A
    PLoS One; 2022; 17(11):e0278137. PubMed ID: 36445914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive rate and quality assessment of CT pulmonary angiography in sickle cell disease: a case‒control study.
    Hassan A; Taleb M; Hasan W; Shehab F; Maki R; Alhamar N
    Emerg Radiol; 2023 Apr; 30(2):209-216. PubMed ID: 36947347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease.
    Savale L; Habibi A; Lionnet F; Maitre B; Cottin V; Jais X; Chaouat A; Artaud-Macari E; Canuet M; Prevot G; Chantalat-Auger C; Montani D; Sitbon O; Galacteros F; Simonneau G; Parent F; Bartolucci P; Humbert M
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31537700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of hypertension and abnormal kidney function in children with sickle cell disease -a cross sectional review.
    Bodas P; Huang A; O'Riordan MA; Sedor JR; Dell KM
    BMC Nephrol; 2013 Oct; 14():237. PubMed ID: 24168027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell disease and venous thromboembolism: A retrospective comparison of the rate of positive CT pulmonary angiography in the emergency department.
    Bates DDB; Liu Z; Gibbons J; LeBedis CA; Holalkere NS
    Eur J Radiol; 2019 Jan; 110():256-259. PubMed ID: 30599869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex as an Independent Risk Factor for Venous Thromboembolism in Sickle Cell Disease: A Cross-Sectional Study.
    Roe AH; McAllister A; Kete C; Pishko A; Whitworth H; Schreiber CA; Sayani FA
    J Womens Health (Larchmt); 2022 Oct; 31(10):1467-1471. PubMed ID: 35675680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.